Enbridge Analyst Sees Risks In Pipeline Projects, Downgrades Stock

Loading...
Loading...

Recent meetings with Enbridge Inc ENB management suggest heightened regulatory and project execution risks for the Line 3 (L3R) and Line 5 pipelines, according to Bank of America Merrill Lynch.

The Analyst

Dennis Coleman downgraded Enbridge from Buy to Neutral with an unchanged CA$49 ($37.35) price target. 

The Thesis

A meeting with Enbridge CEO Al Monaco in New York and with EVP and Chief Development Officer John Whelen in Calgary highlighted uncertainty around the timeline for L3R and the possibility of a prolonged litigation process for Line 5 (L5), Coleman said in the Tuesday downgrade note. (See his track record here.) 

The energy transportation giant projected CA$5-$6 billion in annual self-funding, which supports 5-7% growth in DCF per share in the longer term, the analyst said. While this is positive, more clarity is needed on the company’s “next leg of growth,” he said.

Enbridge’s larger projects continue to face headline risks that could limit near-term upside to the stock, Coleman said. 

The company does have growth opportunities, including connectivity; last-mile prospects; investments in LNG facilities; utility assets; and possible M&A, the analyst said.

"While we are encouraged by these growth prospects, we do not believe ENB’s overall growth potential is outsized compared to peers and believe it could face project capture risks due to sharp competition."

Price Action

Enbridge shares were down 0.33% at $36.05 at the time of publication Tuesday. 

Loading...
Loading...

Related Links:

62 Biggest Movers From Yesterday

50 Stocks Moving In Monday's Mid-Day Session

Public domain photo via Wikimedia

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorDowngradesPrice TargetAnalyst RatingsBank of America Merrill LynchDennis P. Coleman
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...